Incyte Corporation (INCY)
Incyte anuncia que la Comisión Europea aprueba Minjuvi® (tafasitamab) para el tratamiento del linfoma folicular en recaída o refractario
Incyte anuncia que la Comisión Europea aprueba Minjuvi® (tafasitamab) para el tratamiento del linfoma folicular en recaída o refractario
How to Make Your Airpods Louder
Latest About Microsoft Surface Laptop 7
Latest About 27″ Acer Predator X27 Monitor
The Best Laptops for Photo Editing (2026)
What to Do If Your Verizon Is Experiencing an Outage
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
Law Offices of Howard G. Smith Encourages Integer Holdings Corporation (ITGR) Shareholders To Inquire About Securities Fraud Class Action
VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders